DOD Lung Cancer, Patient-Centered Outcomes and Survivorship Award

0 Saves · 2 Shares · 0 Comments Discussion

Grant Name

Funder

Army Medical Research Acquisition Activity (AMRAA)

Department of Defense (DOD)

Country or Region

United States

Research Field

Science and Technology and other Research and Development

Deadline

Aug 07, 2024 12:00:00 AM EDT

Grant Size

2080000

Contact Info

Danielle Reckley Grantor Help@eBRAP.org

Eligibility

Eligible Applicants:

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Grant Number

HT942524LCRPPCOSA

Description

The Patient-Centered Outcomes and Survivorship Award supports high-risk, high-reward research studies that span the spectrum of behavioral health science, survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, co-morbid conditions, and examining the physical, psychological, social, and economic effects of lung cancer among patients and their families.

The overall intent of the FY24 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research studies may include, but are not limited to:

Studies to examine and improve quality of life, decision-making, and symptom and side effect management (e.g., toxicity of treatment, palliative/supportive care, psychological distress and anxiety).

Studies to investigate the impact of prevention, diagnostics, treatment, or health care delivery approaches on health outcomes.

Studies to assess the relationship(s) between behavioral, cognitive, and/or social functioning in relation to lung cancer detection, initiation, progression, treatment, and rehabilitation.

Studies into the psychological health and well-being of those affected by lung cancer (e.g., patients, family members).

Development and testing for efficacy of lifestyle interventions and symptom management approaches to minimize disease risk and maximize quality of life.

Key aspects of this award mechanism are:

Impact: The Patient-Centered Outcomes and Survivorship Award is intended to support research that demonstrates the potential to have a major impact on patient outcomes. Research should challenge paradigms with respect to impact on patient care and outcomes. Proposed projects may include translational or clinical research, including pilot clinical trials. Impactful research will accelerate the movement of promising ideas into clinical applications, generate knowledge to improve clinical guidelines, or significantly advance behavioral, cognitive, and/or social functioning related to the target population.

Study Design: Applications should clearly articulate the chosen design of the study. Basic studies should demonstrate research strategy, feasibility, and how the study relates to the human experience with lung cancer. Studies entailing retrospective or prospective recruitment should define the type of architecture of the study (e.g., descriptive, correlational, field experimental, meta-analyses). Study populations should be defined. The rationale should support the chosen study design with statistical evaluation to back the design. Questionnaires should be described in sufficient detail to justify interpretation of potential results.

Preliminary Data: The Patient-Centered Outcomes and Survivorship Award requires preliminary data for all studies that propose the active (prospective) recruitment of human subjects. Studies not proposing active recruitment of human subjects are not required to present preliminary data but should be supported by sound reasoning and relevant literature.

Patient Advocate Participation: Applications to the Patient-Centered Outcomes and Survivorship Award funding opportunity are encouraged to include a patient advocate. As part of the research team, the patient advocate would assist in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. The patient advocate will be a person with a history of lung cancer diagnosis. As a lay representative, the patient advocate should be active in a cancer advocacy organization. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. The role of the patient advocate should be focused on providing objective input on the research and its potential impact for individuals with or at risk for lung cancer.

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link

Quick share

Add deadline to calendar

Aug 07, 2024 12:00:00 AM EDT

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.

Suggest reading

Canadian Institutes of Health Research Profile

Bill and Melinda Gates Foundation Profile

Empowering Innovation: A Spotlight on the National Science Foundation

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Related opportunities

MRFF – Cardiovascular Health Mission – 2024 Cardiovascular Health Grant Opportunity: Medical Research 31-Jul-2024 $24,000,000.00

DoD Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award: Science and Technology and other Researc... Aug 01, 2024 12:00:00 AM EDT 1200000

DoD Joint Warfighter Medical, Military Medical Research and Development Award: Science and Technology and other Researc... Aug 29, 2024 12:00:00 AM EDT 7400000

DoD Prostate Cancer, Implementation Science Award: Science and Technology and other Researc... Aug 30, 2024 12:00:00 AM EDT 9600000

Use cases for the UNCAN.eu research data platform: Artificial Intelligence 2024-09-18 €30000000

DoD Breast Cancer, Breakthrough Award Levels 1 and 2: Science and Technology and other Researc... Sep 26, 2024 12:00:00 AM EDT 12600000

DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award: Science and Technology and other Researc... Oct 03, 2024 12:00:00 AM EDT 2656000

DoD Bone Marrow Failure, Investigator-Initiated Research Award: Science and Technology and other Researc... Oct 09, 2024 12:00:00 AM EDT 2440000

DoD VRP, Investigator-Initiated Research Award: Science and Technology and other Researc... Nov 08, 2024 12:00:00 AM EST 832000

Market Adjustment Program: Aged Care 30-May-2025 $81,099,000.00

Funding resources